Applications Now Open Research training for life science graduatesThe Cancer Research UK Scotland Centre offers a number of fully funded 4-year PhD studentships, providing an exceptional opportunity to undertake doctoral research within a diverse range of leading laboratories. Each studentship includes a stipend of £22,500 per year from 1 October 2026, along with full tuition fees and research costs.The programme brings together world-class researchers and clinicians across the University of Edinburgh and the University of Glasgow, including the Edinburgh Cancer Research Centre, the CRUK Scotland Institute, and the School of Cancer Sciences. This collaborative environment supports a vibrant, interdisciplinary PhD experience, spanning fundamental discovery science through to translational research. Students benefit from access to cutting-edge facilities in genomics, mass spectrometry, advanced imaging, single-cell & spatial technologies, and computational biology.Up to three CRUK-funded studentships are available for entry in September or October 2026. Successful applicants will be registered at either the University of Edinburgh or the University of Glasgow, depending on their chosen project.We welcome applications from outstanding graduates with at least an upper second-class degree (or equivalent) in a life sciences discipline, a strong interest in experimental research, and a clear commitment to a career in cancer research. Applicants must also meet the relevant English language requirements. Both UK and international candidates are eligible, subject to specific criteria.Applications open approximately 7–8 months prior to the start date and are administered centrally through the University of Edinburgh or the University of Glasgow. When submitting your application please upload the recruitment form below and specify which project (s) from the undernoted you wish to apply for. Please note - only apply here for Edinburgh projects. Document CRUK EDI Form (311.33 KB / DOCX) Closing date: 6th May 2026Interviews: Beginning – mid June 2026 Mechanistic exploration of genetic, environmental, and sex-specific risk factors to reduce colorectal cancer incidence and inequalities Supervisor details: Dr Vidya Rajasekaran, Prof Susan Farrington, Dr Kathryn Pennel Defining the impact of driver-gene heterogeneity on mechanisms of immune evasion and response to therapy in pancreatic cancer. Supervisors: Dr Alan Serrels, Prof Jen Morton, Prof David Chang This article was published on 2026-03-24
